Learning Objectives:

1. Optimize selection of antiplatelet therapies to balance bleeding risk with ischemic benefit.

2. Identify best choices of adjunctive regimens with antiplatelet therapy.

3. Understand influence of duration of therapy on clinical outcomes.

Session date: 
Friday, December 13, 2019 - 12:00pm to 1:00pm
W-632, The Medical Center
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Michael Lincoff, MD